Publications

Publications published since 2000 or in press from OUS - Department of Haematology

447 publications found

Publications in press

1. Abelsson J, Merup M, Birgegård G, Weisbjerrum O, Brinch L, Brune M, Johansson P, Kauppila M, Lenhoff S, Liljeholm M, Malm C, Remes K, Vindelöv L, Andréasson B
   The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
   Bone Marrow Transplant (in press)
   PubMed 21552298
2. Alatri A, Armstrong AE, Greinacher A, Koster A, Kozek-Langenecker SA, Lancé MD, Link A, Nielsen JD, Sandset PM, Spanjersberg AJ, Spannagl M
   Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - An European Perspective
   Thromb Res (in press)
   PubMed 22178575
3. Boon H, Kostovski E, Pirkmajer S, Song M, Lubarski I, Iversen PO, Hjeltnes N, Widegren U, Chibalin AV
   Influence of chronic and acute spinal cord injury on skeletal muscle Na+/K+-ATPase and phospholemman expression in humans
   Am J Physiol Endocrinol Metab (in press)
   PubMed 22275761
4. Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM
   A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
   Thromb Res (in press)
   PubMed 22217510
5. Gruber FX, Lundán T, Goll R, Silye A, Mikkola I, Rekvig OP, Knuutila S, Remes K, Gedde-Dahl T, Porkka K, Hjorth-Hansen H
   BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
   Med Oncol (in press)
   PubMed 21221851
6. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM
   The association of antiphospholipid antibodies with intrauterine fetal death: A case-control study
   Thromb Res (in press)
   PubMed 22178574
7. Holm A, Wu W, Lund-Johansen F
   Antibody array analysis of labelled proteomes: how should we control specificity?
   N Biotechnol (in press)
   PubMed 21840428
8. Ljungman P, Locasciulli A, de Soria VG, Békássy AN, Brinch L, Espigado I, Ferrant A, Franklin IM, O'Riordan J, Rovira M, Shaw P, Einsele H
   Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
   Bone Marrow Transplant (in press)
   PubMed 22158388
9. Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Arauz A et al.
   Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
   Trials, 12 (1), 252 (in press)
   PubMed 22129158
10. Vetlesen A, Holme PA, Lyberg T, Kjeldsen-Kragh J
    Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation
    Transfusion (in press)
    PubMed 22084943
11. Wang Y, Brinch L, Jebsen P, Tanbo T, Kirschner R
    A Clinical Study of Cervical Dysplasia in Long-Term Survivors of Allogeneic Stem Cell Transplantation
    Biol Blood Marrow Transplant (in press)
    PubMed 21963879
12. Wiktor-Jedrzejczak W, Dearden C, de Wreede L, van Biezen A, Brinch L, Leblond V, Brune M, Volin L, Kazmi M, Nagler A, Schetelig J, de Witte T, Dreger P
    Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium
    Leukemia (in press)
    PubMed 22116553

Publications 2012

1. Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2012)
   Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
   Lancet, 379 (9810), 31-8
   PubMed 22172244
2. Stuchlý J, Kanderová V, Fi?er K, Cerná D, Holm A, Wu W, Hru?ák O, Lund-Johansen F, Kalina T (2012)
   An automated analysis of highly complex flow cytometry-based proteomic data
   Cytometry A, 81 (2), 120-9
   PubMed 22213549

Publications 2011

1. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U (2011)
   Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy
   Thromb Res, 127 (6), 540-6
   PubMed 21435698
2. Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
   Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
   Br J Haematol, 154 (2), 241-7
   PubMed 21564075
3. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
   Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
   Leuk Lymphoma, 52 (10), 2007-9
   PubMed 21663503
4. Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
   Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
   Eur J Haematol, 86 (5), 385-95
   PubMed 21332794
5. Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM (2011)
   Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
   J Thromb Haemost, 9 (6), 1261-3
   PubMed 21489133
6. Haugen F, Labori KJ, Noreng HJ, Buanes T, Iversen PO, Drevon CA (2011)
   Altered expression of genes in adipose tissues associated with reduced fat mass in patients with pancreatic cancer
   Arch Physiol Biochem, 117 (2), 78-87
   PubMed 21457003
7. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
   Incidence and risk factors of fetal death in Norway: a case-control study
   Acta Obstet Gynecol Scand, 90 (4), 390-7
   PubMed 21306337
8. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
   The association of inherited thrombophilia and intrauterine fetal death: a case-control study
   Blood Coagul Fibrinolysis, 22 (8), 651-6
   PubMed 22198364
9. Jønsson V, Awan H, Nyquist E, Maisenhølder M, Johannesen TB, Ly B, Tjønnfjord GE (2011)
   Familial Hodgkin's lymphoma in Scandinavia
   In Vivo, 25 (3), 431-7
   PubMed 21576419
10. Karlsen TA, Mirtaheri P, Shahdadfar A, Fløisand Y, Brinchmann JE (2011)
    Effect of three-dimensional culture and incubator gas concentration on phenotype and differentiation capability of human mesenchymal stem cells
    J Cell Biochem, 112 (2), 684-93
    PubMed 21268090
11. Knudsen E, Iversen PO, Bøyum A, Seierstad T, Nicolaysen G, Benestad HB (2011)
    G-CSF enhances the proliferation and mobilization, but not the maturation rate, of murine myeloid cells
    Eur J Haematol, 87 (4), 302-11
    PubMed 21623923
12. Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Østerud B, Sandset PM, Iversen PO (2011)
    Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium
    Blood Coagul Fibrinolysis, 22 (4), 254-9
    PubMed 21297449
13. Krarup LH, Sandset EC, Sandset PM, Berge E (2011)
    D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
    Acta Neurol Scand, 124 (1), 40-4
    PubMed 20726843
14. Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2011)
    Reduced platelet function and role of drugs in acute gastrointestinal bleeding
    Basic Clin Pharmacol Toxicol, 108 (3), 194-201
    PubMed 21118353
15. Kvam AK, Fayers PM, Wisloff F (2011)
    Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
    Eur J Haematol, 87 (4), 330-7
    PubMed 21668504
16. Lassila R, Antovic JP, Armstrong E, Baghaei F, Dalsgaard-Nielsen J, Hillarp A, Holme PA, Holmström M, Johnsson H, Joutsi-Korhonen L, Sandset PM (2011)
    Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia
    Semin Thromb Hemost, 37 (3), 328-36
    PubMed 21455867
17. Lassila R, Holme PA, Landorph A, Petrini P, Onundarson PT, Hillarp A (2011)
    Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease
    Semin Thromb Hemost, 37 (5), 495-502
    PubMed 22102192
18. McInnes H, Kristiansen J, Kristjansson JE, Schyberg H (2011)
    The role of horizontal resolution for polar low simulations
    Q. J. R. Meteorol. Soc., 137 (660), 1674-1687
19. Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA, UK Collaborators of IST (2011)
    Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial
    PLoS One, 6 (3), e16988
    PubMed 21445242
20. Möllgård L, Saft L, Treppendahl MB, Dybedal I, Nørgaard JM, Astermark J, Ejerblad E, Garelius H, Dufva IH, Jansson M, Jädersten M, Kjeldsen L, Linder O, Nilsson L, Vestergaard H, Porwit A, Grønbæk K, Hellström-Lindberg E (2011)
    Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
    Haematologica, 96 (7), 963-71
    PubMed 21719884
21. Negaard HF, Sandset PM, Kolset SO, Svennevig K, Østenstad B, Iversen PO (2011)
    Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
    Leuk Lymphoma, 52 (6), 1157-9
    PubMed 21463121
22. Nilsson-Ehle H, Birgegård G, Samuelsson J, Antunovic P, Astermark J, Garelius H, Engström LM, Kjeldsen L, Nilsson L, Olsson A, Skov-Holm M, Wallvik J, Gulbrandsen N, Hellström-Lindberg E (2011)
    Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ?120?g/L with darbepoetin alfa?±?filgrastim or erythrocyte transfusions
    Eur J Haematol, 87 (3), 244-52
    PubMed 21623919
23. Nyquist KB, Thorsen J, Zeller B, Haaland A, Trøen G, Heim S, Micci F (2011)
    Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12)
    Cancer Genet, 204 (3), 147-52
    PubMed 21504714
24. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
    An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
    J Virol, 85 (13), 6557-66
    PubMed 21490090
25. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
    The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
    Lancet, 377 (9767), 741-50
    PubMed 21316752
26. Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, Björeman M, Flogegård M, Koskenvesa P, Lindblom A, Malm C, Mustjoki S, Myhr-Eriksson K, Ohm L, Räsänen A, Sinisalo M, Själander A, Strömberg U, Bjerrum OW, Ehrencrona H, Gruber F, Kairisto V, Olsson K, Sandin F, Nagler A et al. (2011)
    Combination of pegylated IFN-?2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
    Blood, 118 (12), 3228-35
    PubMed 21685374
27. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2011)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    PubMed 21165555
28. Slaastad H, Wu W, Goullart L, Kanderova V, Tjønnfjord G, Stuchly J, Kalina T, Holm A, Lund-Johansen F (2011)
    Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins
    Proteomics, 11 (23), 4578-82
    PubMed 21956872
29. Stavik B, Skretting G, Aasheim HC, Tinholt M, Zernichow L, Sletten M, Sandset PM, Iversen N (2011)
    Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
    BMC Cancer, 11, 357
    PubMed 21849050
30. Tangen JM, Jaworska A, Mattsson H (2011)
    The Fukushima accident--health consequences
    Tidsskr Nor Laegeforen, 131 (23), 2342-3
    PubMed 22139113
31. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2011)
    Protein C mutation (A267T) results in ER retention and unfolded protein response activation
    PLoS One, 6 (8), e24009
    PubMed 21901152
32. Tran HT, Tjønnfjord GE, Paus A, Holme PA (2011)
    rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency
    Haemophilia, 17 (5), 764-70
    PubMed 21707871
33. Westerberg AC, Schei R, Henriksen C, Smith L, Veierød MB, Drevon CA, Iversen PO (2011)
    Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid
    Acta Paediatr, 100 (1), 47-52
    PubMed 20624152
34. Wik HS, Enden TR, Jacobsen AF, Sandset PM (2011)
    Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity
    J Thromb Haemost, 9 (10), 1931-6
    PubMed 21848904

Publications 2010

1. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
   Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
   Leukemia, 24 (11), 1901-9
   PubMed 20844564
2. Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K, European Haemophilia Therapy Standardisation Board (2010)
   Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
   Haemophilia, 16 (5), 747-66
   PubMed 20398077
3. Austbø L, Røed KH, Dolvik NI, Skretting G (2010)
   Identification of differentially expressed genes associated with osteochondrosis in standardbred horses using RNA arbitrarily primed PCR
   Anim Biotechnol, 21 (2), 135-9
   PubMed 20379890
4. Awan H, Jønsson V, Johannesen TB, Ly B, Tjønnfjord GE (2010)
   Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders
   Transl Oncogenomics, 4, 1-9
   PubMed 21566766
5. Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, Jacobsen EM, Thoresen AS, Beiske K, Tjønnfjord GE (2010)
   High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
   Blood, 116 (17), 3180-4
   PubMed 20634373
6. Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad M, Sandset PM (2010)
   The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis--a population-based case-control study
   Thromb Res, 125 (5), e222-7
   PubMed 20051285
7. Bjornaas MA, Jacobsen EM, Jacobsen D (2010)
   Nonfatal self-poisoning with LMW heparin and the use of antidote
   Thromb Res, 126 (5), e403-5
   PubMed 20870279
8. Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR (2010)
   Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
   J Thromb Haemost, 8 (5), 1130-2
   PubMed 20149077
9. Enden T, Storås TH, Negård A, Haig Y, Sandvik L, Gjesdal KI, Sandset PM, Kløw NE (2010)
   Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA)
   J Magn Reson Imaging, 31 (2), 416-24
   PubMed 20099355
10. Fløisand Y, Sioud M (2010)
    Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
    Methods Mol Biol, 629, 507-23
    PubMed 20387168
11. Ghanima W, Holme PA, Tjønnfjord GE (2010)
    [Immune thrombocytopenia--pathophysiology and treatment]
    Tidsskr Nor Laegeforen, 130 (21), 2120-3
    PubMed 21052113
12. Gimsing P, Carlson K, Turesson I, Fayers P, Waage A, Vangsted A, Mylin A, Gluud C, Juliusson G, Gregersen H, Hjorth-Hansen H, Nesthus I, Dahl IM, Westin J, Nielsen JL, Knudsen LM, Ahlberg L, Hjorth M, Abildgaard N, Andersen NF, Linder O, Wisløff F (2010)
    Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
    Lancet Oncol, 11 (10), 973-82
    PubMed 20863761
13. Grövdal M, Karimi M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Holm MS, Tangen JM, Wallvik J, Oberg G, Hokland P, Jacobsen SE, Porwit A, Hellström-Lindberg E (2010)
    Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
    Br J Haematol, 150 (3), 293-302
    PubMed 20497178
14. Ha L, Hauge T, Iversen PO (2010)
    Body composition in older acute stroke patients after treatment with individualized, nutritional supplementation while in hospital
    BMC Geriatr, 10, 75
    PubMed 20955603
15. Ha L, Hauge T, Spenning AB, Iversen PO (2010)
    Individual, nutritional support prevents undernutrition, increases muscle strength and improves QoL among elderly at nutritional risk hospitalized for acute stroke: a randomized, controlled trial
    Clin Nutr, 29 (5), 567-73
    PubMed 20176418
16. Iversen PO, Andersson KB, Finsen AV, Sjaastad I, von Lueder TG, Sejersted OM, Attramadal H, Christensen G (2010)
    Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
    Am J Physiol Regul Integr Comp Physiol, 298 (3), R808-14
    PubMed 20032264
17. Iversen PO, Sørensen DR, Sioud M (2010)
    A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
    Thromb Haemost, 104 (2), 350-4
    PubMed 20539915
18. Iversen PO, Wisløff F, Gulbrandsen N (2010)
    Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support
    Clin Nutr, 29 (4), 488-91
    PubMed 20044183
19. Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM (2010)
    Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
    J Thromb Haemost, 8 (11), 2443-9
    PubMed 20735725
20. Jensen K, Schaffer L, Olstad OK, Bechensteen AG, Hellebostad M, Tjønnfjord GE, Kierulf P, Gautvik KM, Osnes LT (2010)
    Striking decrease in the total precursor B-cell compartment during early childhood as evidenced by flow cytometry and gene expression changes
    Pediatr Hematol Oncol, 27 (1), 31-45
    PubMed 20121553
21. Johnsen HE, Klausen TW, Boegsted M, Lenhoff S, Gimsing P, Christiansen I, Gedde-Dahl T, Lindås R, Mellqvist UH, Nordic Myeloma Study Group (2010)
    Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group
    Clin Lymphoma Myeloma Leuk, 10 (4), 290-6
    PubMed 20709667
22. Jønsson V, Tjønnfjord GE, Johannesen TB, Ly B, Olsen JH, Yuille M (2010)
    Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order
    In Vivo, 24 (1), 85-95
    PubMed 20133982
23. Kostovski E, Iversen PO, Hjeltnes N (2010)
    [Complications of chronic spinal cord injury]
    Tidsskr Nor Laegeforen, 130 (12), 1242-5
    PubMed 20567276
24. Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J, Ketterer N, Catovsky D, Ethell M, Matutes E, Dearden CE (2010)
    Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
    Br J Haematol, 149 (6), 907-10
    PubMed 20201944
25. Kvam AK, Fayers P, Wisloff F (2010)
    What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
    Eur J Haematol, 84 (4), 345-53
    PubMed 20041946
26. Kvam AK, Wisløff F, Fayers PM (2010)
    Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
    Health Qual Life Outcomes, 8, 79
    PubMed 20678240
27. Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM (2010)
    Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy
    Blood Coagul Fibrinolysis, 21 (6), 516-21
    PubMed 20453636
28. Opstad TB, Pettersen AA, Bratseth V, Arnesen H, Seljeflot I (2010)
    The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease
    Pathophysiol Haemost Thromb, 37 (2-4), 98-103
    PubMed 21555871
29. Perry D, Berntorp E, Tait C, Dolan G, Holme PA, Laffan M, Lassila R, Mumford A, Pasi J, Wilde J, Will A, Yee TT (2010)
    FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
    Haemophilia, 16 (1), 80-9
    PubMed 19780845
30. Ruland CM, Holte HH, Røislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaløy SO, Hasund L, Ellison MC (2010)
    Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial
    J Am Med Inform Assoc, 17 (4), 403-10
    PubMed 20595307
31. Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2010)
    Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)
    Int J Stroke, 5 (5), 423-7
    PubMed 20854630
32. Sandset PM (2010)
    Immunobiology of heparin-induced thrombocytopenia
    Curr Top Microbiol Immunol, 341, 193-202
    PubMed 20369319
33. Sandset PM, Arnesen H, Jacobsen AF, Wergeland H (2010)
    Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump
    Thromb Res, 126 (3), e232-4
    PubMed 20553950
34. Sandset PM, Francis C (2010)
    Thrombosis Research--affiliation with the European Thrombosis Research Organization (ETRO)
    Thromb Res, 125 (1), 1
    PubMed 20171348
35. Semaeva E, Tenstad O, Skavland J, Enger M, Iversen PO, Gjertsen BT, Wiig H (2010)
    Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammation
    J Immunol, 184 (8), 4547-56
    PubMed 20237290
36. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    PubMed 20384870
37. Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010)
    Functional characterization of polymorphisms in the human TFPI gene
    Biochem Biophys Res Commun, 397 (1), 106-11
    PubMed 20519147
38. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    Tidsskr Nor Laegeforen, 130 (6), 590-1
    PubMed 20348990
39. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    Tidsskr Nor Laegeforen, 130 (6), 591
    PubMed 20348994
40. Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N (2010)
    Overexpression of both TFPI? and TFPI? induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells
    Mol Carcinog, 49 (11), 951-63
    PubMed 20886581
41. Tangen JM, Fløisand Y, Haukås E, Naess IA, Skjelbakken T, Stapnes C, Tjønnfjord GE (2010)
    [Survival in adults with acute lymphoblastic leukaemia]
    Tidsskr Nor Laegeforen, 130 (17), 1710-3
    PubMed 20835280
42. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2010)
    Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport
    BMC Cell Biol, 11, 67
    PubMed 20815936
43. Tjeldhorn L, Sandset PM, Haugbro K, Skretting G (2010)
    Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis
    Thromb Res, 125 (3), 230-4
    PubMed 19535131
44. Westerberg AC, Henriksen C, Ellingvåg A, Veierød MB, Júlíusson PB, Nakstad B, Aurvåg AK, Rønnestad A, Grønn M, Iversen PO, Drevon CA (2010)
    First year growth among very low birth weight infants
    Acta Paediatr, 99 (4), 556-62
    PubMed 20096031
45. Wiig H, Tenstad O, Iversen PO, Kalluri R, Bjerkvig R (2010)
    Interstitial fluid: the overlooked component of the tumor microenvironment?
    Fibrogenesis Tissue Repair, 3, 12
    PubMed 20653943
46. Waage A, Gimsing P, Fayers P, Abildgaard N, Ahlberg L, Björkstrand B, Carlson K, Dahl IM, Forsberg K, Gulbrandsen N, Haukås E, Hjertner O, Hjorth M, Karlsson T, Knudsen LM, Nielsen JL, Linder O, Mellqvist UH, Nesthus I, Rolke J, Strandberg M, Sørbø JH, Wisløff F, Juliusson G, Turesson I et al. (2010)
    Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Blood, 116 (9), 1405-12
    PubMed 20448107

Publications 2009

1. Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A (2009)
   Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin
   Thromb Res, 124 (3), 262-7
   PubMed 19162303
2. Akkök CA, Holte MR, Tangen JM, Ostenstad B, Bruserud O (2009)
   Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells
   Transfusion, 49 (2), 354-61
   PubMed 18980622
3. Andresen PA, Heimdal K, Aaberg K, Eklo K, Ariansen S, Silye A, Fausa O, Aabakken L, Aretz S, Eide TJ, Gedde-Dahl T (2009)
   APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
   J Cancer Res Clin Oncol, 135 (10), 1463-70
   PubMed 19444466
4. Astermark J, Negrier C, Hermans C, Holme PA, Klamroth R, Kotsi P, de Moerloose P, Pasi J, Rocino A, von Depka M, Windyga J, Ludlam CA, Interdisciplinary Working Group IDWG (2009)
   European curriculum for thrombosis and haemostasis
   Haemophilia, 15 (1), 337-44
   PubMed 19149857
5. Berentsen S, Sundic T, Hervig T, Tjønnfjord GE (2009)
   [Autoimmune hemolytic anemia]
   Tidsskr Nor Laegeforen, 129 (21), 2226-31
   PubMed 19898570
6. Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N, Gregersen H, Low E, Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group (2009)
   UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
   Br J Haematol, 147 (1), 22-42
   PubMed 19673884
7. Damås JK, Landrø L, Fevang B, Heggelund L, Tjønnfjord GE, Fløisand Y, Halvorsen B, Frøland SS, Aukrust P (2009)
   Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication
   Clin Exp Immunol, 157 (3), 400-7
   PubMed 19664149
8. Enden T, Garratt AM, Kløw NE, Sandset PM (2009)
   Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire
   Scand J Caring Sci, 23 (2), 369-74
   PubMed 19068041
9. Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM, CaVenT study group (2009)
   Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency
   J Thromb Haemost, 7 (8), 1268-75
   PubMed 19422443
10. Haram K, Svendsen E, Abildgaard U (2009)
    The HELLP syndrome: clinical issues and management. A Review
    BMC Pregnancy Childbirth, 9, 8
    PubMed 19245695
11. Henriksen C, Westerberg AC, Rønnestad A, Nakstad B, Veierød MB, Drevon CA, Iversen PO (2009)
    Growth and nutrient intake among very-low-birth-weight infants fed fortified human milk during hospitalisation
    Br J Nutr, 102 (8), 1179-86
    PubMed 19445820
12. Holme PA, Glomstein A, Grønhaug S, Tjønnfjord GE (2009)
    Home treatment with bypassing products in inhibitor patients: a 7.5-year experience
    Haemophilia, 15 (3), 727-32
    PubMed 19320748
13. Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
    Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
    Transl Oncol, 2 (4), 242-6
    PubMed 19956385
14. Kardel KR, Johansen B, Voldner N, Iversen PO, Henriksen T (2009)
    Association between aerobic fitness in late pregnancy and duration of labor in nulliparous women
    Acta Obstet Gynecol Scand, 88 (8), 948-52
    PubMed 19562561
15. Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
    Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
    Eur J Haematol, 83 (4), 279-89
    PubMed 19558508
16. Micci F, Panagopoulos I, Haugom L, Andersen HK, Tjønnfjord GE, Beiske K, Heim S (2009)
    t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia
    Cancer Lett, 277 (2), 205-11
    PubMed 19168282
17. Michalsen S, Schrumpf E, Beiske K, Tierens A, Stenberg V, Tjønnfjord GE (2009)
    [Large granular lymphocytic leukaemia]
    Tidsskr Nor Laegeforen, 129 (11), 1098-102
    PubMed 19488091
18. Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, Hjorth-Hansen H, Höglund M, Kovanen P, Laurinolli T, Liesveld J, Paquette R, Pinilla-Ibarz J, Rauhala A, Shah N, Simonsson B, Sinisalo M, Steegmann JL, Stenke L, Porkka K (2009)
    Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
    Leukemia, 23 (8), 1398-405
    PubMed 19295545
19. Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B, Iversen PO (2009)
    Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
    Leukemia, 23 (1), 162-9
    PubMed 18800145
20. Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Østenstad B, Sandset PM, Iversen PO (2009)
    Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas
    Leuk Lymphoma, 50 (6), 998-1004
    PubMed 19373600
21. Rehn TA, Borge BA, Lunde PK, Munkvik M, Sneve ML, Grøndahl F, Aronsen JM, Sjaastad I, Prydz K, Kolset SO, Wiig H, Sejersted OM, Iversen PO (2009)
    Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats
    Am J Physiol Regul Integr Comp Physiol, 297 (1), R26-33
    PubMed 19339678
22. Reseland JE, Reppe S, Olstad OK, Hjorth-Hansen H, Brenne AT, Syversen U, Waage A, Iversen PO (2009)
    Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma
    Eur J Haematol, 83 (5), 460-70
    PubMed 19572994
23. Sandset PM, Francis C (2009)
    Thrombosis Research: Introduction of e-pages
    Thromb Res, 124 (3), 251
    PubMed 19596224
24. Sandset PM, Francis C, Key N (2009)
    Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    Thromb Res, 124 (5), 515
    PubMed 19837232
25. Sandset PM, Høibraaten E, Eilertsen AL, Dahm A (2009)
    Mechanisms of thrombosis related to hormone therapy
    Thromb Res, 123 Suppl 2, S70-3
    PubMed 19217481
26. Skretting G, Lien T, Sandset PM, Iversen N (2009)
    Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability
    Thromb Res, 123 (6), 851-5
    PubMed 19007969
27. Slot KB, Berge E (2009)
    Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement
    J Stroke Cerebrovasc Dis, 18 (1), 17-22
    PubMed 19110139
28. Slot KB, Berge E, Sandercock P, Lewis SC, Dorman P, Dennis M, Oxfordshire Community Stroke Project, Lothian Stroke Register, International Stroke Trial (UK) (2009)
    Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts
    Stroke, 40 (5), 1585-9
    PubMed 19265057
29. Slot KB, Murray V, Boysen G, Berge E (2009)
    Thrombolytic treatment for stroke in the Scandinavian countries
    Acta Neurol Scand, 120 (4), 270-6
    PubMed 19456310
30. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    PubMed 19284496
31. Sørby R, Austbø L, Press CM, Skretting G, Landsverk T, Espenes A (2009)
    PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie
    PLoS One, 4 (9), e6885
    PubMed 19727393
32. Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
    Age and stress related phenotypical changes in bone marrow CD34+ cells
    Scand J Clin Lab Invest, 69 (1), 79-84
    PubMed 18836945
33. Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P (2009)
    Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases
    Acta Haematol, 122 (1), 11-6
    PubMed 19641300
34. Vik A, Holme PA, Singh K, Dorenberg E, Nordhus KC, Kumar S, Hansen JB (2009)
    Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities
    Cardiovasc Intervent Radiol, 32 (5), 980-7
    PubMed 19641959

Publications 2008

1. Austbø L, Kampmann A, Müller-Ladner U, Neumann E, Olsaker I, Skretting G (2008)
   Identification of differentially expressed genes in ileal Peyer's patch of scrapie-infected sheep using RNA arbitrarily primed PCR
   BMC Vet Res, 4, 12
   PubMed 18373840
2. Benestad HB, Wisløff F (2008)
   [Research ethics and University of Oslo]
   Tidsskr Nor Laegeforen, 128 (15), 1683-4
   PubMed 18704143
3. Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
   [Allogeneic stem cell transplantation in acute myelogenous leukemia]
   Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
   PubMed 18704137
4. Crowther-Swanepoel D, Wild R, Sellick G, Dyer MJ, Mauro FR, Cuthbert RJ, Jonsson V, Matutes E, Dearden C, Wiley J, Fuller S, Catovsky D, Houlston RS (2008)
   Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL
   Blood, 111 (12), 5691-3
   PubMed 18424666
5. Dahm AE, Sandset PM, Rosendaal FR (2008)
   The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
   J Thromb Haemost, 6 (2), 393-5
   PubMed 18045239
6. Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM (2008)
   Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method
   BJOG, 115 (6), 773-9
   PubMed 18355366
7. Eilertsen AL, Sandvik L, Steinsvik B, Sandset PM (2008)
   Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers
   J Thromb Haemost, 6 (6), 928-34
   PubMed 18394014
8. Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
   [Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
   Tidsskr Nor Laegeforen, 128 (22), 2563-6
   PubMed 19023351
9. Fløisand Y, Normann AP, Heim S, Lund-Johansen F, Tjønnfjord GE (2008)
   High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia
   Scand J Clin Lab Invest, 68 (2), 93-8
   PubMed 17852828
10. Ha L, Iversen PO, Hauge T (2008)
    [Nutrition for elderly acute stroke patients]
    Tidsskr Nor Laegeforen, 128 (17), 1946-50
    PubMed 18787570
11. Haga HJ, Jacobsen EM, Peen E (2008)
    Incidence of thromboembolic events in patients with primary Sjögren's syndrome
    Scand J Rheumatol, 37 (2), 127-9
    PubMed 18415770
12. Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
    [Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
    Tidsskr Nor Laegeforen, 128 (21), 2440-2
    PubMed 19096466
13. Holme PA, Michelsen AE (2008)
    [A 40-year old woman with dizziness and vomiting]
    Tidsskr Nor Laegeforen, 128 (12), 1413-5
    PubMed 18584769
14. Iversen PO, Ukrainchenko E, Afanasyev B, Hulbekkmo K, Choukah A, Gulbrandsen N, Wisløff F, Tangen JM (2008)
    Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia
    Leuk Lymphoma, 49 (10), 1916-24
    PubMed 18949615
15. Jacobsen AF, Skjeldestad FE, Sandset PM (2008)
    Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study
    Am J Obstet Gynecol, 198 (2), 233.e1-7
    PubMed 17997389
16. Jacobsen AF, Skjeldestad FE, Sandset PM (2008)
    Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study
    J Thromb Haemost, 6 (6), 905-12
    PubMed 18363820
17. Johannesen TB, Ly B, Samuelsen SO, Tjønnfjord GE, Jønsson V (2008)
    [A new study of chronic lymphatic leukemia in Norway]
    Tidsskr Nor Laegeforen, 128 (6), 713
    PubMed 18337855
18. Jädersten M, Malcovati L, Dybedal I, Della Porta MG, Invernizzi R, Montgomery SM, Pascutto C, Porwit A, Cazzola M, Hellström-Lindberg E (2008)
    Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome
    J Clin Oncol, 26 (21), 3607-13
    PubMed 18559873
19. Jønsson V, Samuelsen SO, Tjønnfjord G, Johannesen T (2008)
    Looking for CLL genes
    Leuk Lymphoma, 49 (1), 10-1
    PubMed 18203003
20. Jønsson V, Tjønnfjord GE, Johannesen TB, Samuelsen SO, Ly B (2008)
    Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders
    Transl Oncogenomics, 3, 15-20
    PubMed 21566740
21. Kolstad A, Tjønnfjord G, Jønsson V (2008)
    High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT
    Bone Marrow Transplant, 42 (6), 427-8
    PubMed 18587433
22. Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS (2008)
    Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
    Clin Exp Immunol, 152 (1), 57-63
    PubMed 18241231
23. Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y, IRIS (International Randomized Interferon vs STI571) Study Group (2008)
    Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
    Blood, 111 (8), 4022-8
    PubMed 18256322
24. Mellqvist UH, Lenhoff S, Johnsen HE, Hjorth M, Holmberg E, Juliusson G, Tangen JM, Westin J, Nordic Myeloma Study Group (2008)
    Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone
    Cancer, 112 (1), 129-35
    PubMed 17973267
25. Negaard HF, Iversen PO, Ostenstad B, Mowinckel MC, Sandset PM (2008)
    Increased acquired activated protein C resistance in unselected patients with hematological malignancies
    J Thromb Haemost, 6 (9), 1482-7
    PubMed 18573186
26. Negaard HF, Iversen PO, Østenstad B, Iversen N, Holme PA, Sandset PM (2008)
    Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor
    Thromb Haemost, 99 (6), 1040-8
    PubMed 18521506
27. Olsen AL, Johannesen TB, Ly B, Samuelsen SO, Tjonnfjord G, Jonsson V (2008)
    Pleiotropy in families with chronic lymphocytic leukemia
    Salud Cienc., 15 (8), 1236-+
28. Piehler AP, Gulbrandsen N, Kierulf P, Urdal P (2008)
    Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population
    Clin Chem, 54 (11), 1823-30
    PubMed 18801937
29. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P et al. (2008)
    Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
    Trials, 9, 37
    PubMed 18559104
30. Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G, IST-3 Collaborative Group (2008)
    EPITHET--where next?
    Lancet Neurol, 7 (7), 570-1; author reply 571-3
    PubMed 18565447
31. Schjesvold FH, Sjo M, Tangen JM, Hammerstrøm J, Brinch L (2008)
    [High-dose treatment of systemic AL-amyloidosis with autologous stem cell support]
    Tidsskr Nor Laegeforen, 128 (12), 1392-6
    PubMed 18552900
32. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P, Oxfordshire Community Stroke Project, the International Stroke Trial (UK), Lothian Stroke Register (2008)
    Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies
    BMJ, 336 (7640), 376-9
    PubMed 18230644
33. Slot KB, Berge E, Wardlaw J (2008)
    Haemorrhagic transformation of a recent silent cerebral infarct during thrombolytic stroke treatment
    BMJ Case Rep, 2008, bcr0620080266
    PubMed 21716819
34. Stelljes M, van Biezen A, Slavin S, Olavarria E, Clark RE, Nagler A, Koza V, Kienast J, Niederwieser D, de Witte T, Ruutu T, complications subcommittee of the Chronic Leukemia Working Party (2008)
    The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 42 (11), 739-42
    PubMed 18724394
35. Tangen JM, Fløisand Y, Foss-Abrahamsen J, Haukås E, Naess IA, Skjelbakken T (2008)
    [Survival in adults with acute myelogenous leukemia]
    Tidsskr Nor Laegeforen, 128 (10), 1164-7
    PubMed 18480864
36. van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM (2008)
    Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
    J Thromb Haemost, 6 (2), 346-51
    PubMed 18067603
37. Aasbrenn M, Langmark F, Wisløff F (2008)
    [Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?]
    Tidsskr Nor Laegeforen, 128 (23), 2712-4
    PubMed 19079417

Publications 2007

1. Abildgaard U (2007)
   Antithrombin--early prophecies and present challenges
   Thromb Haemost, 98 (1), 97-104
   PubMed 17597998
2. Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J (2007)
   Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
   Vox Sang, 93 (1), 42-8
   PubMed 17547564
3. Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2007)
   Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
   Thromb Res, 120 (1), 21-7
   PubMed 16914186
4. Andresen MS, Eilertsen AL, Abildgaard U, Sandset PM (2007)
   Hormone therapy and raloxifene reduce the coagulation inhibitor potential
   Blood Coagul Fibrinolysis, 18 (5), 455-60
   PubMed 17581320
5. Andresen PA, Johansen T, Eide TJ, Gedde-Dahl T (2007)
   Gene symbol: APC
   Hum Genet, 121 (2), 288
   PubMed 17598199
6. Austbø L, Espenes A, Olsaker I, Press CM, Skretting G (2007)
   Increased PrP mRNA expression in lymphoid follicles of the ileal Peyer's patch of sheep experimentally exposed to the scrapie agent
   J Gen Virol, 88 (Pt 7), 2083-90
   PubMed 17554044
7. Berentsen S, Beiske K, Tjønnfjord GE (2007)
   Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy
   Hematology, 12 (5), 361-70
   PubMed 17891600
8. Berentsen S, Ulvestad E, Tjønnfjord GE (2007)
   B-lymphocytes as targets for therapy in chronic cold agglutinin disease
   Cardiovasc Hematol Disord Drug Targets, 7 (3), 219-27
   PubMed 17896962
9. Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM (2007)
   The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
   Stroke, 38 (3), 1069-71
   PubMed 17290027
10. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group (2007)
    An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
    Eur J Cancer, 43 (11), 1670-8
    PubMed 17574838
11. Dahlqvist J, Klar J, Hausser I, Anton-Lamprecht I, Pigg MH, Gedde-Dahl T, Gånemo A, Vahlquist A, Dahl N (2007)
    Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis
    J Med Genet, 44 (10), 615-20
    PubMed 17557927
12. Dalgaard J, Fløisand Y, Stenersen M, Egeland T, Brinch L (2007)
    [Non-myeloablative allogeneic stem cell transplantation]
    Tidsskr Nor Laegeforen, 127 (6), 721-4
    PubMed 17363982
13. Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM (2007)
    Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system
    Thromb Haemost, 97 (6), 938-43
    PubMed 17549295
14. Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM (2007)
    Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis
    Thromb Res, 120 (3), 371-9
    PubMed 17156824
15. Enden T, Sandvik L, Kløw NE, Hafsahl G, Holme PA, Holmen LO, Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM (2007)
    Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
    Am Heart J, 154 (5), 808-14
    PubMed 17967583
16. Frøyland M, Thompson KM, Thorpe SJ, Sahota SS, Gedde-Dahl T, Bogen B (2007)
    A VH4-34+ myeloma protein with weak autoreactivity
    Haematologica, 92 (5), 690-3
    PubMed 17488696
17. Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, Wisloff F, Marziali S, Morboeuf O, Barbui T (2007)
    Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
    Blood, 110 (4), 1178-83
    PubMed 17440049
18. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Ross S, Sandset PM (2007)
    D-dimer level is associated with the extent of pulmonary embolism
    Thromb Res, 120 (2), 281-8
    PubMed 17030057
19. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Sandset PM (2007)
    The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE
    J Intern Med, 261 (1), 74-81
    PubMed 17222170
20. Ghanima W, Nielssen BE, Holmen LO, Witwit A, Al-Ashtari A, Sandset PM (2007)
    Multidetector computed tomography (MDCT) in the diagnosis of pulmonary embolism: interobserver agreement among radiologists with varied levels of experience
    Acta Radiol, 48 (2), 165-70
    PubMed 17354136
21. Ghanima W, Sandset PM (2007)
    Risk stratification of pulmonary embolism by computed tomography
    J Intern Med, 262 (6), 702
    PubMed 17944881
22. Ghanima W, Sandset PM (2007)
    Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE)
    Thromb Res, 120 (4), 471-6
    PubMed 17161451
23. Grövdal M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Wallvik J, Tangen JM, Oberg G, Jacobsen SE, Hokland P, Porwit A, Hellström-Lindberg E (2007)
    Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome
    Clin Cancer Res, 13 (23), 7107-12
    PubMed 18056190
24. Holme PA (2007)
    [Deficient thrombosis prophylaxis]
    Tidsskr Nor Laegeforen, 127 (9), 1176
    PubMed 17479132
25. Jensen T, Kierulf P, Sandset PM, Klingenberg O, Joø GB, Godal HC, Skjønsberg OH (2007)
    Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells
    Thromb Haemost, 97 (5), 822-9
    PubMed 17479194
26. Johannessen MK, Skretting G, Ytrehus B, Røed KH (2007)
    Neonatal growth cartilage: equine tissue specific gene expression
    Biochem Biophys Res Commun, 354 (4), 975-80
    PubMed 17276390
27. Jønsson V, Tjønnfjord G, Samuelsen SO, Johannesen T, Olsen J, Sellick G, Houlston R, Yuille M, Catovsky D (2007)
    Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease
    Leuk Lymphoma, 48 (12), 2387-96
    PubMed 18067015
28. Kvale EO, Fløisand Y, Lund-Johansen F, Rollag H, Farkas L, Ghanekar S, Brandtzaeg P, Jahnsen FL, Olweus J (2007)
    Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells
    Blood, 109 (8), 3369-76
    PubMed 17158235
29. Liestøl S, Sandset PM, Jacobsen EM, Mowinckel MC, Wisløff F (2007)
    Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
    Br J Haematol, 136 (1), 131-7
    PubMed 17092306
30. Liestøl S, Sandset PM, Mowinckel MC, Wisløff F (2007)
    Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
    J Thromb Haemost, 5 (11), 2204-10
    PubMed 17958739
31. Micci F, Panagopoulos I, Tjønnfjord GE, Kolstad A, Delabie J, Beiske K, Heim S (2007)
    Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies
    Virchows Arch, 450 (5), 559-65
    PubMed 17406891
32. Nicolaysen A, Gammelsaeter R, Storm-Mathisen J, Gundersen V, Iversen PO (2007)
    The components required for amino acid neurotransmitter signaling are present in adipose tissues
    J Lipid Res, 48 (10), 2123-32
    PubMed 17600303
33. Osuji N, Beiske K, Randen U, Matutes E, Tjonnfjord G, Catovsky D, Wotherspoon A (2007)
    Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia
    Histopathology, 50 (5), 547-54
    PubMed 17394489
34. Rand-Hendriksen S, Tjeldhorn L, Lundby R, Semb SO, Offstad J, Andersen K, Geiran O, Paus B (2007)
    Search for correlations between FBN1 genotype and complete Ghent phenotype in 44 unrelated Norwegian patients with Marfan syndrome
    Am J Med Genet A, 143A (17), 1968-77
    PubMed 17663468
35. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    PubMed 17853407
36. Strauss G, Osen W, Knape I, Jacobsen EM, Müller SM, Debatin KM (2007)
    Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity
    Cell Death Differ, 14 (3), 480-8
    PubMed 16902496
37. Tchaikovski SN, van Vliet HA, Thomassen MC, Bertina RM, Rosendaal FR, Sandset PM, Helmerhorst FM, Tans G, Rosing J (2007)
    Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography
    Thromb Haemost, 98 (6), 1350-6
    PubMed 18064335
38. Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
    Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
    Leukemia, 21 (10), 2203-4
    PubMed 17525727
39. Tjønnfjord GE, Holme PA (2007)
    Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
    Vasc Health Risk Manag, 3 (4), 527-31
    PubMed 17969383
40. Torfoss D, Høiby EA, Tangen JM, Holte H, Bø K, Meyer P, Grøttum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaløy S (2007)
    Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
    J Antimicrob Chemother, 59 (4), 711-7
    PubMed 17327294
41. Villa I, Kvale EO, Lund-Johansen F, Olweus J (2007)
    Assay for monitoring in vitro selective depletion strategies in allogeneic stem cell transplantation
    Cytotherapy, 9 (6), 600-10
    PubMed 17882725
42. Wisløff F (2007)
    [Epoetin in cancer treatment--the end of the game?]
    Tidsskr Nor Laegeforen, 127 (18), 2359
    PubMed 17895937
43. Wisløff F, Kvam AK, Hjorth M, Lenhoff S (2007)
    Serum calcium is an independent predictor of quality of life in multiple myeloma
    Eur J Haematol, 78 (1), 29-34
    PubMed 17038019

Publications 2006

1. Austbø L, Espenes A, Olsaker I, Press CM, Skretting G (2006)
   Lymphoid follicles of the ileal Peyer's patch of lambs express low levels of PrP, as demonstrated by quantitative real-time RT-PCR on microdissected tissue compartments, in situ hybridization and immunohistochemistry
   J Gen Virol, 87 (Pt 11), 3463-71
   PubMed 17030883
2. Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sørbø JH, Tjønnfjord GE (2006)
   Primary chronic cold agglutinin disease: a population based clinical study of 86 patients
   Haematologica, 91 (4), 460-6
   PubMed 16585012
3. Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, Porwit-MacDonald A, Sjoo M, Tangen JM, Uggla B, Oberg G, Hellstrom-Lindberg E (2006)
   Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes
   Haematologica, 91 (5), 667-70
   PubMed 16670072
4. Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO (2006)
   Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
   J Thromb Haemost, 4 (8), 1840-2
   PubMed 16879232
5. Dahm A, Rosendaal FR, Andersen TO, Sandset PM (2006)
   Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state
   Br J Haematol, 132 (3), 333-8
   PubMed 16409298
6. Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
   Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
   BMC Cardiovasc Disord, 6, 40
   PubMed 17029634
7. Dahm AE, Iversen PO, Hjeltnes N, Sandset PM (2006)
   Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
   Thromb Res, 118 (2), 281-7
   PubMed 16139333
8. Eilertsen AL, Qvigstad E, Andersen TO, Sandvik L, Sandset PM (2006)
   Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation
   Maturitas, 55 (3), 278-87
   PubMed 16713143
9. Enden T, Kløw NE, Sandset PM (2006)
   [Catheter-directed thrombolysis in acute deep venous thrombosis]
   Tidsskr Nor Laegeforen, 126 (13), 1765
   PubMed 16794675
10. Farkas L, Kvale EO, Lund-Johansen F, Jahnsen FL (2006)
    Plasmacytoid dendritic cells induce a distinct cytokine pattern in virus-specific CD4+ memory T cells that is modulated by CpG oligodeoxynucleotides
    Scand J Immunol, 64 (4), 404-11
    PubMed 16970682
11. Frangu M, Gedde-Dahl T, Verder H (2006)
    [Epidermolysis bullosa simplex Dowling-Meara]
    Ugeskr Laeger, 168 (48), 4222-4
    PubMed 17147951
12. Ghanima W, Abdelnoor M, Mowinckel MC, Sandset PM (2006)
    The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism
    Br J Haematol, 132 (2), 210-5
    PubMed 16398655
13. Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
    Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
    Clin Exp Immunol, 144 (3), 418-24
    PubMed 16734610
14. Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G (2006)
    Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
    Eur Heart J, 27 (9), 1038-47
    PubMed 16476694
15. Jacobsen EM, Trettenes EJ, Wisløff F, Abildgaard U (2006)
    Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
    Thromb J, 4, 3
    PubMed 16436199
16. Jensen T, Retterstøl LJ, Sandset PM, Godal HC, Skjønsberg OH (2006)
    A daily glass of red wine induces a prolonged reduction in plasma viscosity: a randomized controlled trial
    Blood Coagul Fibrinolysis, 17 (6), 471-6
    PubMed 16905951
17. Jønsson V (2006)
    [Inheritance and cancer]
    Ugeskr Laeger, 168 (24), 2327
    PubMed 16822411
18. Jønsson V, Bock JE, Hilden J, Houlston RS, Wiik A (2006)
    The influence of pregnancy on the development of autoimmunity in chronic lymphocytic leukemia
    Leuk Lymphoma, 47 (8), 1481-7
    PubMed 16966257
19. Jønsson V, Johannesen TB (2006)
    Anticipation in lymphoproliferative disorders
    Leuk Lymphoma, 47 (10), 2015-6
    PubMed 17071471
20. Jønsson V, Olsen JH (2006)
    [Inheritance in lymphoproliferative disorders]
    Ugeskr Laeger, 168 (24), 2361-6
    PubMed 16822421
21. Kildahl-Andersen O, Thorstensen K, Sagen E, Dahl IM, Tjønnfjord G (2006)
    [A 40-year-old woman with anemia]
    Tidsskr Nor Laegeforen, 126 (22), 2958-9
    PubMed 17144048
22. Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2006)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    Blood, 107 (5), 2022-9
    PubMed 16269620
23. Lenhoff S, Hjorth M, Turesson I, Westin J, Gimsing P, Wislöff F, Ahlberg L, Carlson K, Christiansen I, Dahl IM, Forsberg K, Brinch L, Hammerström J, Johnsen HE, Knudsen LM, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Nordic Myeloma Study Group (2006)
    Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
    Haematologica, 91 (9), 1228-33
    PubMed 16956822
24. Lenhoff S, Hjorth M, Westin J, Brinch L, Bäckström B, Carlson K, Christiansen I, Dahl IM, Gimsing P, Hammerström J, Johnsen HE, Juliusson G, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Tangen JM, Turesson I, Nordic Myeloma Study Group (2006)
    Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group
    Br J Haematol, 133 (4), 389-96
    PubMed 16643445
25. Lotfi K, Karlsson K, Fyrberg A, Juliusson G, Jonsson V, Peterson C, Eriksson S, Albertioni F (2006)
    The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
    Biochem Pharmacol, 71 (6), 882-90
    PubMed 16436271
26. Mathisen B, Loennechen T, Gedde-Dahl T, Winberg JO (2006)
    Fibroblast heterogeneity in collagenolytic response to colchicine
    Biochem Pharmacol, 71 (5), 574-83
    PubMed 16378602
27. Negaard HF, Eilertsen AL, Dahm A, Iversen PO, Østenstad B, Sandset PM (2006)
    Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
    J Clin Oncol, 24 (17), 2683-4; author reply 2684
    PubMed 16763285
28. Njaastad AM, Abildgaard U (2006)
    Bleeding in patients with mechanical heart valves on warfarin: impact of target INR and of comorbidity
    J Intern Med, 260 (6), 596
    PubMed 17116014
29. Njaastad AM, Abildgaard U, Lassen JF (2006)
    Gains and losses of warfarin therapy as performed in an anticoagulation clinic
    J Intern Med, 259 (3), 296-304
    PubMed 16476107
30. O'Donnell MJ, Berge E, Sandset PM (2006)
    Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?
    Stroke, 37 (2), 452-5
    PubMed 16410483
31. Osuji N, Matutes E, Tjonnfjord G, Grech H, Del Giudice I, Wotherspoon A, Swansbury JG, Catovsky D (2006)
    T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature
    Cancer, 107 (3), 570-8
    PubMed 16795070
32. Roed KH, Hasle G, Midthjell V, Skretting G, Leinaas HP (2006)
    Identification and characterization of 17 microsatellite primers for the tick, Ixodes ricinus, using enriched genomic libraries
    Mol. Ecol. Notes, 6 (4), 1165-1167
33. Ruland C, Røslien J, Bakken S, Kristiansen J (2006)
    Comparing tailored computerized symptom assessments to interviews and questionnaires
    AMIA Annu Symp Proc, 1081
    PubMed 17238700
34. Sandset PM (2006)
    [How to make warfarin treatment successful?]
    Tidsskr Nor Laegeforen, 126 (2), 187
    PubMed 16415945
35. Sandset PM (2006)
    Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions
    J Thromb Haemost, 4 (1), 68-9
    PubMed 16409452
36. Schneppenheim R, Kremer Hovinga JA, Becker T, Budde U, Karpman D, Brockhaus W, Hrachovinová I, Korczowski B, Oyen F, Rittich S, von Rosen J, Tjønnfjord GE, Pimanda JE, Wienker TF, Lämmle B (2006)
    A common origin of the 4143insA ADAMTS13 mutation
    Thromb Haemost, 96 (1), 3-6
    PubMed 16807643
37. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
    Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
    J Mol Biol, 364 (5), 945-54
    PubMed 17049554
38. Smith A, Wisloff F, Samson D, UK Myeloma Forum, Nordic Myeloma Study Group, British Committee for Standards in Haematology (2006)
    Guidelines on the diagnosis and management of multiple myeloma 2005
    Br J Haematol, 132 (4), 410-51
    PubMed 16412016
39. Tjeldhorn L, Rand-Hendriksen S, Gervin K, Brandal K, Inderhaug E, Geiran O, Paus B (2006)
    Rapid and efficient FBN1 mutation detection using automated sample preparation and direct sequencing as the primary strategy
    Genet Test, 10 (4), 258-64
    PubMed 17253931
40. Tjønnfjord GE (2006)
    Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA
    Semin Hematol, 43 (2 Suppl 4), S18-21
    PubMed 16690372
41. Aamot HV, Tjønnfjord GE, Delabie J, Heim S (2006)
    Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14)
    Cancer Genet Cytogenet, 165 (2), 172-5
    PubMed 16527613

Publications 2005

1. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
   Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
   Haematologica, 90 (1), 86-93
   PubMed 15642674
2. Andresen MS, Abildgaard U (2005)
   Coagulation Inhibitor Potential: a study of assay variables
   Thromb Res, 115 (6), 519-26
   PubMed 15792684
3. Crowther MA, Wisloff F (2005)
   Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis
   Thromb Res, 115 (1-2), 3-8
   PubMed 15567446
4. Dahm AE, Andersen TO, Rosendaal F, Sandset PM (2005)
   A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
   J Thromb Haemost, 3 (4), 651-8
   PubMed 15842349
5. de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM (2005)
   Determinants of the APTT- and ETP-based APC sensitivity tests
   J Thromb Haemost, 3 (7), 1488-94
   PubMed 15978106
6. Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM (2005)
   The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis
   Maturitas, 52 (2), 111-8
   PubMed 16186073
7. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T (2005)
   A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
   J Thromb Haemost, 3 (5), 848-53
   PubMed 15869575
8. Ghanima W, Almaas V, Aballi S, Dörje C, Nielssen BE, Holmen LO, Almaas R, Abdelnoor M, Sandset PM (2005)
   Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study
   J Thromb Haemost, 3 (9), 1926-32
   PubMed 16102097
9. Gruber FX, Lamark T, Anonli A, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B (2005)
   Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
   Leukemia, 19 (12), 2159-65
   PubMed 16224487
10. Guren TK, Christoffersen T, Thoresen GH, Wisløff F, Dajani O, Tveit KM (2005)
    [Antineoplastic agents targeting tyrosine kinases]
    Tidsskr Nor Laegeforen, 125 (22), 3115-9
    PubMed 16299568
11. Haram K, Björge L, Sandset PM (2005)
    Successful preconceptional prophylactic treatment with combined acetyl salicylic acid and low-molecular heparin (Fragmin) in a case of antiphospholipid-antibody syndrome with prior life-threatening hemolysis, elevated liver enzymes and low-platelet syndrome: a case report
    Acta Obstet Gynecol Scand, 84 (12), 1213-4
    PubMed 16305714
12. Hippe E, Westin J, Wislöff F (2005)
    Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care
    Eur J Haematol, 74 (3), 185-93
    PubMed 15693787
13. Holme PA, Brosstad F, Tjønnfjord GE (2005)
    Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies
    Haemophilia, 11 (5), 510-5
    PubMed 16128896
14. Iversen PO, Wiig H (2005)
    Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis
    Clin Cancer Res, 11 (19 Pt 1), 6793-9
    PubMed 16203766
15. Jädersten M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellström-Lindberg E (2005)
    Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
    Blood, 106 (3), 803-11
    PubMed 15840690
16. Jønsson V, Houlston RS, Catovsky D, Yuille MR, Hilden J, Olsen JH, Fajber M, Brandt B, Sellick G, Allinson R, Wiik A (2005)
    CLL family 'Pedigree 14' revisited: 1947-2004
    Leukemia, 19 (6), 1025-8
    PubMed 15800670
17. Liestøl S, Wisløff F (2005)
    Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays
    Thromb Res, 115 (6), 509-17
    PubMed 15792683
18. Mishra V, Andresen S, Brinch L, Kvaløy S, Ernst P, Lønset MK, Tangen JM, Wikelund J, Flatum C, Baggerød E, Helle B, Vaaler S, Hagen TP (2005)
    Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study
    Bone Marrow Transplant, 35 (12), 1149-53
    PubMed 15880133
19. Mishra V, Paus AC, Tjønnfjord GE (2005)
    [Surgery in patients with bleeding disorders--expensive treatment for a small group of patients]
    Tidsskr Nor Laegeforen, 125 (7), 883-5
    PubMed 15815735
20. Negaard H, Dahm A, Sandset PM, Iversen PO, Ostenstad B (2005)
    Angiogenesis and hemostasis in hematological neoplasias
    Curr. Drug Targets, 6 (6), 681-699
21. Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B (2005)
    Angiogenesis and hemostasis in hematological neoplasias
    Curr Drug Targets, 6 (6), 683-99
    PubMed 16178801
22. Reitan JB, Brinch L, Beiske K (2005)
    Multi-organ failure aspects of a fatal radiation accident in Norway in 1982
    BJR Suppl, 27, 36-40
    PubMed 15975870
23. Schulman S, Tjønnfjord GE, Wallensten R, Martinowitz U, Kenet G (2005)
    Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII
    Thromb Haemost, 94 (6), 1177-80
    PubMed 16411390
24. Sellick GS, Webb EL, Allinson R, Matutes E, Dyer MJ, Jonsson V, Langerak AW, Mauro FR, Fuller S, Wiley J, Lyttelton M, Callea V, Yuille M, Catovsky D, Houlston RS (2005)
    A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci
    Am J Hum Genet, 77 (3), 420-9
    PubMed 16080117
25. Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N (2005)
    A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility
    Scand J Infect Dis, 37 (6-7), 455-64
    PubMed 16012006
26. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    PubMed 16178798
27. Tjønnfjord GE (2005)
    [Polycythemia vera]
    Tidsskr Nor Laegeforen, 125 (19), 2649
    PubMed 16273739
28. Tjønnfjord GE (2005)
    [Anticoagulation therapy and oral surgery]
    Tidsskr Nor Laegeforen, 125 (21), 2999; author reply 2999
    PubMed 16276400
29. Trydal T, Bolann B, Brosstad F, Sandberg S, Sandset PM, Stavelin A, Steensland H, Thue G, Ødegaard OR (2005)
    [Analysis of prothrombin time in primary health care]
    Tidsskr Nor Laegeforen, 125 (15), 2048-9
    PubMed 16100552
30. Wisløff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P (2005)
    Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes
    Eur J Haematol, 75 (4), 293-8
    PubMed 16146535
31. Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, Jacobsen SE (2005)
    IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells
    J Immunol, 174 (2), 752-7
    PubMed 15634895

Publications 2004

1. Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
   The ability of three global plasma assays to recognize thrombophilia
   Thromb Res, 113 (6), 411-7
   PubMed 15226097
2. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, Ghanima W, Shammas FV, Tjønnfjord GE (2004)
   Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
   Blood, 103 (8), 2925-8
   PubMed 15070665
3. Brodin E, Børvik T, Sandset PM, Bønaa KH, Nordøy A, Hansen JB (2004)
   Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study
   Thromb Haemost, 92 (1), 178-84
   PubMed 15213859
4. Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B (2004)
   Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models
   Cancer Immunol Immunother, 53 (9), 759-69
   PubMed 15088126
5. Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F (2004)
   Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides
   J Allergy Clin Immunol, 114 (2), 436-43
   PubMed 15316529
6. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE (2004)
   [Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab]
   Tidsskr Nor Laegeforen, 124 (6), 768-70
   PubMed 15039804
7. Ghanima W, Kahrs J, Dahl TG, Tjonnfjord GE (2004)
   Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia
   Eur J Haematol, 72 (6), 441-3
   PubMed 15128424
8. Gniadecki R, Rossen K, Ralfkier E, Thomsen K, Skovgaard GL, Jønsson V (2004)
   CD56+ lymphoma with skin involvement: clinicopathologic features and classification
   Arch Dermatol, 140 (4), 427-36
   PubMed 15096371
9. Gulbrandsen N, Hjermstad MJ, Wisløff F, Nordic Myeloma Study Group (2004)
   Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences
   Eur J Haematol, 72 (3), 172-80
   PubMed 14962235
10. Heldal D, Brinch L, Evensen SA, Tjønnfjord GE, Aamodt G, Elgjo K, Sviland L (2004)
    Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow
    Bone Marrow Transplant, 34 (4), 345-50
    PubMed 15170163
11. Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004)
    A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation
    Bone Marrow Transplant, 34 (3), 257-66
    PubMed 15170167
12. Hjort PF, Sandset PM, Abildgaard U, Rao LV, Mast A, Ott I, Bajaj SP (2004)
    Tissue factor pathway inhibitor revisited
    J Thromb Haemost, 2 (12), 2241-9
    PubMed 15613032
13. Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM (2004)
    Deep vein thrombosis after elective cesarean section
    Thromb Res, 113 (5), 283-8
    PubMed 15183039
14. Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjønsberg OH (2004)
    The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen
    Thromb Res, 113 (1), 51-6
    PubMed 15081565
15. Klar J, Gedde-Dahl T, Larsson M, Pigg M, Carlsson B, Tentler D, Vahlquist A, Dahl N (2004)
    Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13
    J Med Genet, 41 (3), 208-12
    PubMed 14985385
16. Koss-Harnes D, Høyheim B, Jonkman MF, de Groot WP, de Weerdt CJ, Nikolic B, Wiche G, Gedde-Dahl T (2004)
    Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation
    Acta Derm Venereol, 84 (2), 124-31
    PubMed 15206692
17. Lindahl TL, Egberg N, Hillarp A, Ødegaard OR, Edlund B, Svensson J, Sandset PM, Rånby M (2004)
    INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
    Thromb Haemost, 91 (6), 1223-31
    PubMed 15175811
18. Lund MB, Brinch L, Kongerud J, Boe J (2004)
    Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide
    Eur Respir J, 23 (6), 901-5
    PubMed 15219005
19. Ly B, Njaastad AM, Sandbaek G, Solstrand R, Rosales A, Slagsvold CE (2004)
    [Catheter-directed thrombolysis of iliofemoral venous thrombosis]
    Tidsskr Nor Laegeforen, 124 (4), 478-80
    PubMed 14983192
20. Lyngstadaas A, Husebekk A, Funderud S, Brinch L (2004)
    [Clinical use of haematopoietic stem cells from cord blood]
    Tidsskr Nor Laegeforen, 124 (22), 2928-31
    PubMed 15550970
21. Rodriguez-Merchan EC, Rocino A, Ewenstein B, Bartha L, Batorova A, Goudemand J, Gringeri A, Joao-Diniz M, Lopaciuk S, Negrier C, Quintana M, Tagariello G, Tjonnfjord GE, Villar VA, Vorlova Z (2004)
    Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement
    Haemophilia, 10 Suppl 2, 50-2
    PubMed 15385047
22. Russell D, Thomassen L, Indredavik B, Sandset PM, Joakimsen O, Berge E (2004)
    [Patients with acute brain infarction should receive thrombolytic therapy]
    Tidsskr Nor Laegeforen, 124 (12), 1666-7
    PubMed 15229721
23. Sandset PM (2004)
    [Risk of venous thrombosis and smoking]
    Tidsskr Nor Laegeforen, 124 (15), 1937
    PubMed 15318411
24. Sandset PM, Abildgaard U (2004)
    Tissue factor pathway inhibitor revisited
    J. Thromb. Haemost., 2 (12), 2242-2243
25. Solberg EE, Ekeberg O, Holen A, Ingjer F, Sandvik L, Standal PA, Vikman A (2004)
    Hemodynamic changes during long meditation
    Appl Psychophysiol Biofeedback, 29 (3), 213-21
    PubMed 15497620
26. Tiercy JM, Passweg J, van Biezen A, Zander A, Kröger N, Gratwohl A, Chapuis B, Helg C, Brinch L, Cornelissen J, Oudshoorn M, Ruutu T, Volin L, Niederwieser D, Roosnek E, Chronic Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT) (2004)
    Isolated HLA-C mismatches in unrelated donor transplantation for CML
    Bone Marrow Transplant, 34 (3), 249-55
    PubMed 15195077
27. Tjønnfjord GE (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience
    Haemophilia, 10 Suppl 2, 41-5
    PubMed 15385045
28. Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX
    Haemophilia, 10 (2), 174-8
    PubMed 14962207
29. Wisløff F (2004)
    [Total survival as quality indicator]
    Tidsskr Nor Laegeforen, 124 (23), 3096; author reply 3096
    PubMed 15586201
30. Wisløff F, Crowther M (2004)
    Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure
    Thromb Res, 114 (2), 75-81
    PubMed 15306148
31. Waage A, Gimsing P, Juliusson G, Turesson I, Gulbrandsen N, Eriksson T, Hjorth M, Nielsen JL, Lenhoff S, Westin J, Wislöff F, Nordic Myeloma Study Group (2004)
    Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
    Br J Haematol, 125 (2), 149-55
    PubMed 15059136

Publications 2003

1. Amundsen HF, Stray-Pedersen A, Tjønnfjord GE, Abrahamsen TG (2003)
   [Patients with severe chronic neutropenia]
   Tidsskr Nor Laegeforen, 123 (5), 621-3
   PubMed 12683187
2. Amundsen HF, Stray-Pedersen A, Tjønnfjord GE, Abrahamsen TG (2003)
   [Chronic neutropenia--subtypes and treatment]
   Tidsskr Nor Laegeforen, 123 (5), 624-6
   PubMed 12683188
3. Astermark J, Voorberg J, Lenk H, DiMichele D, Shapiro A, Tjönnfjord G, Berntorp E (2003)
   Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro
   Haemophilia, 9 (5), 567-72
   PubMed 14511295
4. Bendz B, Sandset PM (2003)
   Acute hypoxia and activation of coagulation
   Lancet, 362 (9388), 997-8
   PubMed 14511938
5. Bergheim J, Ernst P, Brinch L, Gore DM, Chetty MC, Stewart GW (2003)
   Allogeneic bone marrow transplantation for severe post-splenectomy thrombophilic state in leaky red cell membrane haemolytic anaemia of the stomatocytosis class
   Br J Haematol, 121 (1), 119-22
   PubMed 12670341
6. Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM (2003)
   Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
   Blood, 101 (11), 4387-92
   PubMed 12560220
7. Dueland S, Sauer T, Lund-Johansen F, Ostenstad B, Tveit KM (2003)
   Epidermal growth factor receptor inhibition induces trichomegaly
   Acta Oncol, 42 (4), 345-6
   PubMed 12899508
8. Dybedal I, Yang L, Bryder D, Aastrand-Grundstrom I, Leandersson K, Jacobsen SE (2003)
   Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression
   Blood, 102 (1), 118-26
   PubMed 12637333
9. Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J (2003)
   A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
   Leuk Res, 27 (4), 323-8
   PubMed 12531223
10. Haram K, Trovik J, Sandset PM, Hordnes K (2003)
    Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome
    Acta Obstet Gynecol Scand, 82 (7), 679-80
    PubMed 12790854
11. Hast R, Hellström-Lindberg E, Ohm L, Björkholm M, Celsing F, Dahl IM, Dybedal I, Gahrton G, Lindberg G, Lerner R, Linder O, Löfvenberg E, Nilsson-Ehle H, Paul C, Samuelsson J, Tangen JM, Tidefelt U, Turesson I, Wahlin A, Wallvik J, Winquist I, Oberg G, Bernell P (2003)
    No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease
    Leukemia, 17 (9), 1827-33
    PubMed 12970783
12. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Albrechtsen D, Aamodt G, Evensen SA (2003)
    Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
    Bone Marrow Transplant, 32 (3), 257-64
    PubMed 12858196
13. Hellström-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, Linder O, Luthman M, Löfvenberg E, Oberg G, Porwit-MacDonald A, Rådlund A, Samuelsson J, Tangen JM, Winquist I, Wisloff F, Scandinavian MDS Group (2003)
    A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life
    Br J Haematol, 120 (6), 1037-46
    PubMed 12648074
14. Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S (2003)
    The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation
    Psychooncology, 12 (8), 803-13
    PubMed 14681953
15. Iversen PO, Wisløff F (2003)
    [Gaucher disease]
    Tidsskr Nor Laegeforen, 123 (3), 304-7
    PubMed 12640894
16. Jacobsen AF, Qvigstad E, Sandset PM (2003)
    Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
    BJOG, 110 (2), 139-44
    PubMed 12618157
17. Lundin J, Hagberg H, Repp R, Cavallin-Ståhl E, Fredén S, Juliusson G, Rosenblad E, Tjønnfjord G, Wiklund T, Osterborg A (2003)
    Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
    Blood, 101 (11), 4267-72
    PubMed 12543862
18. Majak P, Vikskjold F, Abildgaard U (2003)
    [Hereditary antithrombin deficiency and pregnancy--what is the effective thromboprophylaxis?]
    Tidsskr Nor Laegeforen, 123 (2), 144-6
    PubMed 12607492
19. Mishra V, Vaaler S, Brinch L (2003)
    Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma
    Clin Lab Haematol, 25 (3), 179-84
    PubMed 12755795
20. Nazir M, Stien R, Carlsen E, Jacobsen AF, Nesheim BI (2003)
    Early evaluation of bowel symptoms after primary repair of obstetric perineal rupture is misleading: an observational cohort study
    Dis Colon Rectum, 46 (9), 1245-50
    PubMed 12972970
21. Normann AP, Egeland T, Madshus IH, Heim S, Tjønnfjord GE (2003)
    CD7 expression by CD34+ cells in CML patients, of prognostic significance?
    Eur J Haematol, 71 (4), 266-75
    PubMed 12950236
22. Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
    Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
    J Intern Med, 253 (2), 232-9
    PubMed 12542565
23. Schaadt BK, Hendel HW, Gimsing P, Jønsson V, Pedersen H, Hesse B (2003)
    99mTc-aprotinin scintigraphy in amyloidosis
    J Nucl Med, 44 (2), 177-83
    PubMed 12571206
24. Thomassen L, Sandset PM, Joakimsen O, Indredavik B, Russell D (2003)
    [Intravenous thrombolytic therapy of patients with acute cerebral infarction]
    Tidsskr Nor Laegeforen, 123 (5), 638-9
    PubMed 12683192
25. Virtanen M, Smith SK, Gedde-Dahl T, Vahlquist A, Bowden PE (2003)
    Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis
    J Invest Dermatol, 121 (5), 1013-20
    PubMed 14708600
26. Wisløff F (2003)
    [Financing of enzyme treatment in Gaucher disease]
    Tidsskr Nor Laegeforen, 123 (3), 364
    PubMed 12640908
27. Wisløff F, Brinch L, Hammerstrøm J (2003)
    [National guidelines for treatment of chronic myelogenous leukemia]
    Tidsskr Nor Laegeforen, 123 (2), 157-9
    PubMed 12607495